EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma

NCT00001563 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

NIH

Sponsor class

Conditions

AIDS Related Lymphoma
AIDS-Associated Lymphoma

Interventions

BIOLOGICAL: Filgrastim
BIOLOGICAL: Rituximab
DRUG: EPOCH

Sponsor

National Cancer Institute (NCI)